Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HYET Sweet is a leading European manufacturer and supplier of high-intensity sweeteners, specializing in the production of Aspartame and Acesulfame-K. The company operates the only aspartame production facility in Europe, located in Gravelines, France, which it acquired from Ajinomoto in 2015. HYET Sweet serves the global food, beverage, and pharmaceutical industries, providing high-purity ingredients that meet stringent international quality standards. In the healthcare sector, their pharmaceutical-grade sweeteners are utilized as essential excipients for taste-masking in oral drug formulations. The company's strategic position as a localized European producer provides a robust supply chain for manufacturers seeking high-quality sugar alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HYET Sweet.